Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New orally active taxane, DJ-927, with a promising preclinical profile

April 11, 2002

Inhibitors of VEGF useful for cancer and rheumatoid arthritis described in AstraZeneca patents

April 10, 2002

Cdc25 inhibitor described at AACR meeting as warranting further evaluation as an anticancer agent

April 10, 2002

IDN-5390 as a novel taxane suitable for protracted administration

April 10, 2002

Taiho presents novel anticancer compounds that induce p300 gene expression

April 10, 2002

Selfadministration of new Endostatin formulation in clinical trials

April 10, 2002

Gene-based therapy EG-009 designated orphan drug for high-grade glioma

April 9, 2002

Streptomyces strain discovered to produce new antitumor compounds

April 9, 2002

Potent and selective uPA inhibitors designed by Corvas scientists

April 9, 2002

New vascular damaging agents in development at Angiogene Pharmaceuticals

April 9, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...